The Search for Antiaging Interventions: From Elixirs to Fasting Regimens  by de Cabo, Rafael et al.
Leading Edge
ReviewThe Search for Antiaging Interventions:
From Elixirs to Fasting Regimens
Rafael de Cabo,1,* Didac Carmona-Gutierrez,3 Michel Bernier,1 Michael N. Hall,2 and Frank Madeo3,*
1Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
2Biozentrum, University of Basel, Basel 4056, Switzerland
3Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria
*Correspondence: decabora@mail.nih.gov (R.d.C.), frank.madeo@uni-graz.at (F.M.)
http://dx.doi.org/10.1016/j.cell.2014.05.031
The phenomenon of aging is an intrinsic feature of life. Accordingly, the possibility to manipulate it
has fascinated humans likely since time immemorial. Recent evidence is shaping a picture where
low caloric regimes and exercise may improve healthy senescence, and several pharmacological
strategies have been suggested to counteract aging. Surprisingly, the most effective interventions
proposed to date converge on only a few cellular processes, in particular nutrient signaling, mito-
chondrial efficiency, proteostasis, and autophagy. Here, we critically examine drugs and behaviors
to which life- or healthspan-extending properties have been ascribed and discuss the underlying
molecular mechanisms.Introduction
An organism’s lifespan is inevitably accompanied by the aging
process, which involves functional decline, a steady increase
of a plethora of chronic diseases, and ultimately death. Thus, it
has been an ongoing dream of mankind to improve healthspan
and extend life. In the last century, developed countries have
profited from medical advances, improvements in public health-
care systems, and better living conditions derived from their
socioeconomic power to achieve a remarkable increase in life
expectancy. The current US population reports estimate that
the percentage of people aged 65 years and older in the USA
will increase from 13% in 2010 to 19.3% in 2030. However,
according to the WHO, age itself remains the greatest risk factor
for all major life-threatening disorders, and the number of people
suffering from age-related diseases is anticipated to almost
double over the next two decades. The fact that healthspan
has not increased at the same pace as lifespan is a source of
grave concern (Mercken et al., 2012). Indeed, in 2009–2010
almost 70% of the adult population in the USA was obese or
overweight and one in every three adults suffered from hyperten-
sion (NCHS, 2012). Both obesity and hypertension represent
major risk factors for stroke and cardiovascular disease.
Although weight loss and increase in physical activity are gener-
ally prescribed to avoid such age-associated diseases, only a
small percentage of people have the discipline to change their
lifestyle accordingly (Wing and Phelan, 2005). The prevalence
of age-related pathologies represents major psychological and
social impediments as well as an economic burden that urgently
needs appropriate interventions.
Dietary regimens and drugs that can slow the aging process
continue to raise interest among the general public as well as
the scientific and medical communities. Besides the direct
applicability of such interventions to meet the need for improving
health and longevity, they help provide valuable insights for basicresearch. Indeed, the molecular mechanisms underlying aging-
associated defects appear to be interconnected and affect
the same pathways as those responsible for diseases such as
cancer and cardiovascular disease and neurodegenerative dis-
orders. Therefore, efforts aimed at identifying extrinsic solutions
to slow aging require a two-pronged approach: greater under-
standing of the molecular mechanisms involved in the aging
process and application of this knowledge in a practical
manner. Unfortunately, only a few proposed aging interventions
have received good press, the reasons ranging from their
intrinsic complexities to the multifactorial causes underlying
aging. One of the problems in aging research is the relatively
low reproducibility of experimental findings due to the simple
fact that aging is a long-term process. A lengthy experiment is
more prone to develop artifacts that are difficult to control, hence
increasing the possibilities and time windows for experimental
discrepancies. Furthermore, it is our opinion that some incon-
sistencies in the field have arisen from overinterpretation of life-
span-shortening scenarios associated with aging, where, in
many cases, the reduced lifespan may have rather resulted
from incidental damage.
To consolidate the core of reliable advances in antiaging
research, the present review considers only pharmacological
interventions, regimens, and genetic manipulations that meet
three highly selective criteria: (1) promotion of healthspan and/
or life extension; (2) validation in at least three model organisms;
and (3) confirmation by at least three different laboratories. There
are only a few proposed aging interventions that have met such
stringent criteria: fasting regimens, caloric restriction, exercise,
and the use of low-molecular-weight compounds, including
spermidine, metformin, resveratrol, and rapamycin (Table 1).
From a molecular point of view, these interventions may act
through epigenetic mechanisms (histone acetylation/methyl-
ation), the insulin/TOR pathway, the Ras signaling pathway,Cell 157, June 19, 2014 ª2014 Elsevier Inc. 1515
Table 1. Positive and Negative Effects of Lifestyle and Pharmacological Interventions on Humans; Where No Direct Data Are Available
for Humans, Corresponding Effects on Mice Are Listed
Treatment Positive Effects Negative Effects
Caloric
restriction
decreased body fat, blood pressure, resting heart rate
and improved lipid profile
danger of malnutrition (e.g. neurologic deficits, lowered fertility
and libido, wound healing problems, amenorrhea, osteoporosis,
decreased potential to combat infections)
Fasting
strategies
longer lifespan; decreased hypertension and of other
features of metabolic syndrome; improved verbal memory
loss in the aged and overweight; weight loss in the obese
limited if not integrated with health-associated diets;
might be harmful in children, underweight people and
during pregnancy as well as in some disease states
Exercise prevents cardiovascular diseases, diabetes, osteoporosis,
sarcopenia and depression; prolongs independent
living by the elderly
excessive exercise in the elderly is correlated to mortality
Resveratrol (in mice) prevents oxidative stress in the aging heart,
neurodegeneration, vascular disease and diabetes;
increases lifespan under metabolic stress conditions
(high-fat diet or every other day feeding)
(in humans) at high doses, nausea, gastrointestinal discomfort;
(in mice) at high doses, nephrotoxicity
Rapamycin (in mice) extends lifespan; exerts antiproliferative effects potent immunosuppressive properties; long-term administration
has adverse effects (e.g. impaired wound healing, proteinuria,
or pneumonitis)
Spermidine (in mice) extends lifespan; inhibits neurodegeneration
Metformin (in mice) decreases hepatic gluconeogenesis and
increases insulin sensitivity; lifespan extensionmitochondrial function, proteostasis, autophagy, and stress
resistance. This review summarizes the current knowledge on
these promising approaches and critically evaluates their appli-
cability as antiaging interventions.
Why Do We Age?
The more complex a problem, the more important it may be to
ask simple questions. So, why do we age? Actually, we do
hold the capacity for immortality. The molecular clock in our
germline stem cells, which sustain gamete production, is kept
at zero as evidenced by the fact that our offspring are not born
with the father’s or mother’s age. Then why do somatic cells
age? First, the maintenance of repair activity in all our cells rep-
resents a vast energetic demand and, second, the pressure
of recombination and dying of generations allows organisms to
adapt to changing environments (e.g., ice ages). This implies
that aging may be an atavistic, adaptive and altruistic program,
by which single cells or organisms eventually die for the benefit
of the whole population in a highly coordinated (programmatic)
fashion. In that case, groups harboring individual cells or organ-
isms capable of dying in times of stress (e.g., nutrient deprivation
or starvation) would have a selective evolutionary advantage
over groups in which every single cell or organism is selfish.
In fact, one of Darwin’s most famous theories is that selection
can work at the group level. However, most evolutionary biolo-
gists reject this idea. For instance, Maynard Smith argued that
if groups would altruistically inhibit the generation of offspring,
an egoist would infect and take advantage. August Weismann
maintained that an individual’s demise would depend solely
on the fulfillment of its contribution to the species (sufficient
reproductive activity) and not to the group. Further, aging as
an adaptive program has been questioned because this process
seldom occurs in nature, where most individuals die at relatively
young age due to predators or infection. However, aging may1516 Cell 157, June 19, 2014 ª2014 Elsevier Inc.start early in life. For instance, several lines of evidence indicate
that the general physical fitness of a 30-year-old person is
already less than that of a 20 year old.
The last decade has provided evidence for the existence of
group selection. Within chronologically aged yeast cultures,
single yeast cells induce programmed cell death (PCD) as a
result of the accumulation of oxygen radicals and metacaspase
activation. Genetic disruption of PCD-mediated cell removal
improves short-term survival of aged cultures; however, the
surviving cells lose their ability to regrow, indicating an accu-
mulation of damaged cells in the absence of PCD (Fabrizio
et al., 2004; Herker et al., 2004). Hence, the demise of single
individuals in an aged population has a cleaning function that
allows only the fittest to survive. This evolutionary advantage
can be simulated in a competition experiment carried out be-
tween PCD-functional and -defective yeast populations that
mimic the encounter of a group containing altruistic individuals
with one comprising only the egoistic kind. Strains with
dysfunctional PCD have an initial advantage but are eventually
overgrown and outcompeted by wild-type cells (Fabrizio et al.,
2004; Herker et al., 2004). Features like superoxide levels and
regrowth frequency are connected to PCD, an adaptive mech-
anism required for programmed aging through selective advan-
tage at least in yeast (Fabrizio et al., 2004; Herker et al., 2004).
Many observations argue that programmed aging (sometimes
referred to as a pseudoprogram) also occurs in higher eukary-
otes; for example, the rapid aging after the flowering of annual
plants or the accelerated aging (progeria) of Pacific salmon
after spawning. As to its possibility as a selective advantage
in human populations, Darwin stated in his famous work
The Descent of Man that, ‘‘There can be no doubt that a tribe
including many members who...were always ready to aid one
another and to sacrifice themselves for the common good
would be victorious over most other tribes; and this would be
Figure 1. Health-Promoting Interventions
against Age-Related Diseases
Three distinct approaches are currently being
tested as feasible strategies to counteract a series
of disorders, whose risk of emergence is directly
linked to increased age: (1) specific antiaging
drugs, (2) fasting, which seems best associated
to a beneficial diet that includes low protein
consumption, and (3) periodic exercise. All of
them have been shown to reduce the risk of age-
related diseases in mammalian models, including
neurodegeneration and cardiovascular disease,
among others.natural selection.’’ The existence of some programmatic fea-
tures during aging is a conditio sine qua non for a therapeutic
approach to combat aging. During the last years, several
health-promoting interventions have been confirmed as poten-
tially effective against age-related diseases (Figure 1).
Behavioral Antiaging Interventions
Caloric Restriction
The reduction in the intake of calories without malnutrition is
defined as caloric restriction (CR). Such reduction ideally corre-
sponds to a decrease of approximately 30% of calories per
day, at least in mice. In humans, there is some indication that
a CR of around 15% may be most favorable against mortality
during aging (Willcox and Willcox, 2014). CR reduces
the release of growth factors like growth hormone, insulin,
and insulin-like growth factor 1 (IGF1), which have been shown
to accelerate aging and increase mortality in many organisms
(Fontana et al., 2010). Almost a hundred years ago, long before
knowing about the proaging effects of growth factors, the
connection between lower caloric intake and prolonged life-
span was already described. Since then, CR has been shown
to prolong mean and maximum lifespan in dogs, rodents,
worms, flies, yeasts, and prokaryotes (Fontana et al., 2010).
In unicellular organisms, nutrient deprivation triggers lifespan
extension to probably maximize the chances of reproduction
in the event of future exposure to a nutrient-rich environment.
Importantly, CR-mediated longevity in eukaryotes seems to
be governed by a set of conserved nutrient signaling pathways
(Fontana et al., 2010). Among them are the insulin and the TOR/
S6K pathways, whose inhibition upon CR eventually confers
stress resistance and promotes survival during aging. Stress-
related transcription factors represent the common effectors
in yeast, flies, worms, and mammals (Fontana et al., 2010).
Moreover, the histone deacetylase SIR2 (the founding member
of the sirtuin family) has been linked to CR-mediated antiaging
effects in yeast mother cells, flies, and mammals (Haigis and
Guarente, 2006). Sirtuin-mediated control of protein acetylation
might not be restricted to chromatin packaging and transcrip-
tional modulation, as the mitochondrial sirtuin SIRT3 has been
proposed to play an important role in the prevention of age-
related diseases, possibly through modulation of the mitochon-
drial acetylproteome (Hebert et al., 2013). Of note, in rodents,
moderate CR (8%) positively affects median (not maximal) life-
span, but a more severe (30%) dietary restriction increases life-
span by up to 50%, partly by delaying the emergence of
chronic diseases (Anderson et al., 2009). Interestingly, a recentreport showed that mice with transgenic overexpression of
fibroblast growth factor 21 (FGF21), a fasting hormone, have
extended lifespan when maintained on an ad libitum diet (Zhang
et al., 2012).
The beneficial effects of CR may represent an adaptive evolu-
tionary response forged during evolution to overcome short-
term famine conditions. In that case, the quantitative impact of
lifespan extension relative to the total, natural lifespan of an or-
ganism might be more prominent in short-lived species (like
mice) than in long-lived ones (like primates). Two studies have
addressed the effects of CR on nonhuman primates, but with
different outcomes. The UW (University of Wisconsin-Madison)
study observed prolonged life (Colman et al., 2009) while the
NIA study did not (Mattison et al., 2012). Many parameters
(including husbandry and diet composition) may have strongly
influenced the positive effects of CR. It would appear that the
high sugar (sucrose) concentration contained in the ad libitum
diet (control group) of the UW study (Colman et al., 2009) led
to a shortened lifespan within the cohort of control monkeys,
thus accounting for the lifespan extension when animals were
fed a CR diet. In contrast, the healthier ad libitum diet in the
NIA study (Mattison et al., 2012) allowed for longer lifespan in
control animals without conferring additional benefit from CR.
Hence, a healthy diet might be comparable to a bad diet (high
sugar) plus CR. However, both studies point to the fact that
CR increases healthspan inmonkeys by reducing the risk for dia-
betes, cardiovascular disease, and cancer.
One of the best correlations between CR and improvement
in healthspan and prolonged life in humans is the long-lived pop-
ulation in Okinawa, Japan (Mizushima et al., 1997). In compari-
son to the rest of the Japanese population, Okinawan people
usually combine an above-average amount of daily exercise
with a below-average food intake (Willcox and Willcox, 2014).
However, when Okinawan families moved to Brazil, they adop-
ted a Western lifestyle that impacted both their diet and physical
activity, resulting in increased weight gain and a drop in life
expectancy of 17 years (Mizushima et al., 1997). CR changes
many parameters in the aging human body, including the
transcriptome, the hormonal status (in particular the serum
concentration of IGF-1 and thyroid hormones), oxidative stress,
inflammation, mitochondrial function, and glucose homeostasis
(Fontana et al., 2010). Accumulating evidence suggests that
protein restriction is necessary and sufficient for depletion of
serum IGF1 in humans (Fontana et al., 2010). It remains to be
determined which of these factors, if any, are responsible
for CR-induced lifespan extension. Epigenetic modificationsCell 157, June 19, 2014 ª2014 Elsevier Inc. 1517
observed during aging are another possible target of CR,
although this is based largely on correlative data. Studies with
monozygotic twins suggest the accumulation of epigenetic
changes as they age (e.g., demethylation of 5-methylcytosines
in DNA), thus affecting the transcriptome (Fraga et al., 2005).
Nevertheless, sustenance on a severely restricted diet without
malnutrition (around 30%CR) is arduous and is linked to chronic
low weight and substantial side effects. Studies have shown that
prolonged CR may decrease fertility and libido, create wound
healing problems, and result in amenorrhea, osteoporosis, and
decreased potential to combat infections. Female rats subjected
to prolonged CR become infertile in a reversible fashion (Martin
et al., 2007), and moderate CR may be harmful to lean human
beings (Fontana et al., 2010).
Dietary Strategies Based on CR
Given the disadvantages of CR, a key question remains. How
can CR be a socially and ethically acceptable method to reduce
health risks in the general population? A number of fasting regi-
mens are asserting themselves as suitable strategies, among
them the alternate day fasting diet (Johnson et al., 2007; Varady
et al., 2009), the ‘5:2’ intermittent fasting diet (Harvie et al., 2011),
and a 48 hr fast once or twice each month. When compared to
CR, periodic fasting is psychologically more viable, lacks some
of the negative side effects, and is only accompanied by minimal
weight loss (Heilbronn et al., 2005).
Several lines of evidence indicate that fasting regimens exert
antiaging effects. A lower age-associated morbidity and a longer
lifespan were observed among Spanish home nursing residents
performing alternate day fasting, where residents fasted every
other day with unrestricted food supply on the nonfasting day
(Mercken et al., 2012). In the Biosphere II project, human volun-
teers who were living together for 24 months experienced an
unforeseen severe CR. As a result, metabolic and hormonal
changes, similar to those observed in CR-induced longevity
increase in rodents, were detected. These included low circu-
lating glucose, insulin, and glycated hemoglobin levels, as well
as a decrease in both cholesterol levels and blood pressure
(Walford et al., 2002). Interestingly, food deprivation in adults
during World War II in some European countries has been asso-
ciated with long-term healthspan, but also with detrimental
effects. Indeed, the psychological and physical adversities that
accompany a war situation make it difficult to accurately inter-
pret this involuntary restriction of caloric intake. Food shortage,
especially during the intrauterine phase and childhood, is more
likely to cause malnutrition, thereby resulting in a vast array of
adverse effects. While fasting may prolong life in adult humans,
the results with monkeys are still contentious (see above).
Upon fasting, the body undergoesmajormetabolic changes to
meet its energy needs. After depletion of glycogen stores, it acti-
vates hepatic and nonhepatic gluconeogenesis (e.g., via gluco-
genic amino acids or glycerol) aswell as production of fat-derived
free fatty acids and ketone bodies. For instance, free fatty acids
already appear in the bloodstream after a 12-24 hr fast. The
body’s main source of energy then comes from ketolysis, which
generates acetyl-CoA, andgluconeogenesis-dependent genera-
tion of approximately 80 g of glucose each day, which is mainly
consumed by the brain. Interestingly, a ketone ester diet, which
seemingly recapitulates energymetabolismduring fasting, allevi-1518 Cell 157, June 19, 2014 ª2014 Elsevier Inc.ates proteopathic and behavioral deficiencies in a mouse model
of Alzheimer’s disease (Kashiwaya et al., 2013).
Based on the available evidence, we hypothesize that repeated
fasting and eating cycles—as practiced during periodic fasting
regimens—may circumvent the negative side effects of perma-
nent CR. Of note, rats on an alternate day fasting protocol live
up to 83% longer than their normally fed counterparts, and
a 24 hr fasting period every 4 days is sufficient to promote
a significant lifespan extension (Longo and Mattson, 2014).
Such an intermittent fasting strategy may even yield positive
effects despite overconsumption of calories. Of significance,
mice that were fed a high-fat diet in a time-restricted manner,
i.e., with regular fasting breaks, had lower inflammatory markers
and no fatty liver and were slim in comparison to mice with
equivalent total number of calories consumed ad libitum (Hatori
et al., 2012). From an evolutionary point of view, this form of
feeding pattern may actually reflect mammalian adaptation to
food by overeating in times of nutrient abundance (e.g., after a
successful hunt) andstarvation inbetween.This is also hownative
tribes live today, many of whom show no signs of age-associated
diseases, such as cancer, neurodegeneration, diabetes, cardio-
vascular disease, or hypertension (Gurven et al., 2009).
Healthy Aging to Combat Diseases
Fasting
Fasting rituals are part of most human populations and cultures
that have prevailed to date, including Buddhism, Christianity,
Hinduism, Judaism, and Islam as well as African animistic reli-
gions. It may thus be speculated that such routines that period-
ically limit caloric intake can have health-promoting attributes.
Indeed, fasting has been shown to exert a series of beneficial
effects on healthspan by minimizing the risk of developing age-
related diseases, such as neurodegeneration, cancer, or cardio-
vascular disease, in animal models and, possibly, humans
(Longo and Mattson, 2014). Periodic fasting dampens the dele-
terious consequences of Alzheimer’s, Parkinson’s, and Hunting-
ton’s diseases as well as frontotemporal dementia in various
mouse models, without beneficial effect on amyotrophic lateral
sclerosis (Longo and Mattson, 2014). Fasting cycles have been
reported to be as effective as chemotherapy against certain
tumors in mice. When combined with chemotherapy, a 2 to
3 day fast enhances efficacy of a variety of chemotherapeutic
drugs while reducing their negative side effects in mice (Raffa-
ghello et al., 2008). A treatment that combines fasting and
chemotherapy rendered 20%–60% of mice cancer-free when
inoculated with highly aggressive tumors like glioblastoma or
pancreatic tumors, which killed 100%of the cohort when treated
with chemotherapy alone (Raffaghello et al., 2008). In stark
contrast to normal cells, tumor cells never cease to proliferate
and require enhanced glucose metabolism to meet their high
energy and biosynthetic demands. When faced with starvation,
cancer cells simply die.
The single most effective way to lower hypertension is the
practice of fasting. A two-week period of medically supervised,
water-only fasting resulted in blood pressure readings below
120/80 mm Hg in 82% of subjects with borderline hypertension
(Goldhamer et al., 2002). Ten days of water-only fasting normal-
ized blood pressure readings in all hypertensive patients who
were taking antihypertensive medication (Goldhamer et al.,
2002).
The metabolic syndrome includes a cluster of risk factors,
such as high blood pressure, dyslipidemia, and insulin resis-
tance, that markedly enhances the risk for coronary artery dis-
ease, stroke, and diabetes when combined with obesity. Of
note, while extremely obese people (body mass index [BMI]
above 35) are at 29% higher risk of premature death, moderately
overweight individuals seem to be protected, having lower over-
all mortality risk as compared to normal weight persons (Flegal
et al., 2013). Moderately overweight individuals probably have
better protection in times of disease/crisis and improved
response against infections and toward wound healing (Flegal
et al., 2013). However, the BMI is an insufficient indicator of
body composition and percent body fat. For example, a well-
trained athlete may have a BMI equivalent to that of an obese
individual because of the athlete’s higher muscle mass density.
The waist/hip ratio is a much better indicator for body fat and
an excellent predictor of the odds of dying from cardiovascular
diseases, with lowwaist/hip ratio associated with a lowermortal-
ity risk (Welborn et al., 2003). Several periodic fasting strategies
revert features of metabolic syndrome in overweight and obese
subjects, which coincide with increases in insulin sensitivity and
lipolytic activity (Harvie et al., 2011; Heilbronn et al., 2005; Varady
et al., 2009).
A worldwide sociohistorical turn occurred in 2006 when the
number of deaths related to obesity exceeded those linked to
starvation. Studies on human twins have convincingly demon-
strated that adiposity increases the probability of age-related
dementia and Alzheimer’s disease (Xu et al., 2011). A 3 to
4 month period of CR improves verbal memory in overweight
women and aged people (Witte et al., 2009) despite the fact
that the brain relies mainly on glucose. In line with these obser-
vations, it has been demonstrated that fasting facilitates long-
term memory formation in Drosophila melanogaster (Hirano
et al., 2013). Moreover, alternate day fasting over a period of
2–4 weeks reduces asthma-related symptoms and markers of
oxidative stress in overweight people suffering from asthma
(Johnson et al., 2007). Marked reduction of metabolic disease
markers, such as high blood pressure and levels of circulating
IGF1 and C-reactive protein, has been reported in overweight
women that were subjected to a 2 day per week fast over
6 months (Harvie et al., 2011). Similarly, aged men on an eating
plan involving 2 days of fasting each week lose weight and expe-
rienced fewer bouts of depression (Teng et al., 2011). However,
the efficacy of most fasting strategies as they relate to medical
conditions and/or agingmight be limited if they are not integrated
with diets that have health-associated benefits, such as the
Mediterranean diet or the Okinawa low-protein diet. It should
also be noted that fasting might even be harmful to certain indi-
viduals (e.g., children and underweight people) and in some
disease states (e.g., type 1 diabetes or extreme hypertension),
where fasting can result in severe health consequences and
possible death unless performed under medical supervision.
Exercise
In rodents as in humans, regular exercise can reduce the risk
of morbidity and mortality (Holloszy and Schechtman, 1991;
Huffman et al., 2011; Pekkanen et al., 1987; Samorajski et al.,1985). Given that cardiovascular diseases are strongly associ-
ated with aging in humans (but not in mice), the effects of exer-
cise on human health may be even stronger than in animal
models. Indeed, an increase in aerobic exercise in the elderly
is associated with favorable outcomes on blood pressure, lipids,
glucose tolerance, bone density, and depression (Fleg, 2012).
Similar positive results also occur upon episodic fasting. Thus,
exercise training can have a beneficial impact against diseases
andmetabolic disorders that typically accompany aging, notably
cardiovascular diseases, diabetes, and osteoporosis (Fontana
et al., 2010). Consumption of energy-dense, nutrient-poor food
along with a sedentary lifestyle has a compounding effect on
these disorders (Pereira et al., 2005). The loss of abdominal fat
and reduction in the waist/hip ratio (rather than BMI) contribute
to the protection against these age-related disorders (Welborn
et al., 2003). Moderate or even low levels of exercise (e.g., daily
30 min walks) without weight loss have a positive effect in obese
subjects (Laaksonen et al., 2005) by inhibiting the development
of the metabolic syndrome (Huffman et al., 2011). Prolonged
independent living by the elderly can be achieved through regu-
lar physical activity (Nicklas and Brinkley, 2009), but excessive
exercise in the elderly is correlated to mortality and needs to
be controlled in this population (Lee and Skerrett, 2001). Exer-
cise is the only known treatment that can prevent or even reverse
sarcopenia, a chronic disease associated with age-related loss
of muscle strength and function (Glass and Roubenoff, 2010).
Contrary to CR, regular exercise fails to extend lifespan
(Mercken et al., 2012) despite its clear benefits at improving
health-related quality of life. Moreover, the combination of exer-
cise andCR has no additive effect onmaximal lifespan in rodents
(Holloszy and Schechtman, 1991). Because exercise and CR do
reveal distinct molecular signatures (Mercken et al., 2013), it is
likely that the integration of regular exercise with CR results in
synergistic health-promoting effects. From a socio-evolutionary
point of view, this synergy can be quite advantageous. Hunger
forces individuals to move and hunt. Alternate day fasting
combined with exercise is more beneficial for muscle mass
than exercise alone (Sakamoto and Grunewald, 1987). In nonob-
ese subjects, CR combined with exercise has synergistic effects
on insulin sensitivity and the lowering of circulating C-reactive
protein (Solomon et al., 2010). Still, CR and exercise seem
to be mechanistically connected to some extent, since both
starvation and exercise induce autophagy through disruption
of the BCL-2-beclin-1 complex (He et al., 2012).
Pharmacological Antiaging Interventions
Although virtually all obese people know that stable weight loss
would reduce their elevated risk for metabolic diseases and
enhance their overall odds for survival, only 20% of overweight
individuals are able to lose 10% of their weight for a period of
at least 1 year (Wing and Phelan, 2005). A similar behavior can
be found in most of the population with regard to food choice
and exercise, possibly because the acute satisfaction of comfort
overrides the potential long-term benefits that lifestyle changes
bring. Thus, drugs that may work as CR mimetics have drawn
broad attention in recent years (Figure 2), with some of them
yielding promising results in current antiaging trials (Cloughesy
et al., 2008; Patel et al., 2011).Cell 157, June 19, 2014 ª2014 Elsevier Inc. 1519
Figure 2. Molecular Targets for Caloric Restriction and Pharmacological Interventions against Premature Aging
Caloric restriction promotes longevity through sirtuin activation as well as through inhibition of the insulin and TOR pathways, which both lead to stress resistance
and autophagy activation. Resveratrol, rapamycin, and spermidine exert autophagy-dependent antiaging mechanisms that are exerted both at the cytosolic and
nuclear levels. Whether resveratrol directly interacts with the sirtuin family member SIRT1 remains controversial. Metformin promotes AMPK activity and prevents
oxidative damage. Ac, acetyl residue; HAT, histone acetyltransferase; AMPK, adenosine monophosphate-activated protein kinase; AKT/PKB, protein kinase B;
CR, caloric restriction.Resveratrol is a polyphenol that is found in grapes and in red
wine. Its potential to promote lifespan was first identified in yeast
(Howitz et al., 2003), and it has since gained fame because it was
suggested to be responsible for the so-called French paradox
(French winemakers do not suffer from cardiovascular diseases
though enjoying a high-fat diet). In monkeys fed a diet high in
sugar and fat, resveratrol supplementation attenuated peripheral
inflammation in adipose tissue (Jimenez-Gomez et al., 2013),
maintained pancreatic homeostasis by preventing b cell dedif-
ferentiation (Fiori et al., 2013), and improved vascular function,
particularly pulse wave velocity (Mattison et al., 2014). Resvera-
trol treatment prolongs the lifespan of mice fed a high-fat diet or
fed every other day (Baur et al., 2006), but not of mice on regular
chow. This polyphenolic compound prolongs the life of flies
(Bauer et al., 2004), worms (Baur and Sinclair, 2006), and the
replicative lifespan of yeast (Howitz et al., 2003), but not yeast’s
chronological lifespan (unpublished data). However, recent data
claim that the degree of lifespan extension in worms and flies on
a resveratrol-supplemented diet may be shorter than previously
reported (Burnett et al., 2011). Nevertheless, resveratrol offers
protection in models of stress- and age-associated diseases,
including chronic overfeeding, insulin resistance, type 2 dia-
betes, and cardiovascular dysfunction (Baur et al., 2006;
Lagouge et al., 2006). The mechanisms behind these effects
may rely on the fact that resveratrol mimics some of the meta-
bolic actions of CR, as a series of studies on humans have sug-
gested (Timmers et al., 2012). Resveratrol interacts with many
stress-related targets in the cell, including the mammalian
NAD+-dependent deacetylase SIRT1 (Baur and Sinclair, 2006;
Lagouge et al., 2006), although the resveratrol-SIRT1 interaction
may be indirect (Beher et al., 2009). SIRT1 is a member of a1520 Cell 157, June 19, 2014 ª2014 Elsevier Inc.family of proteins (sirtuins) that have been linked to longevity in
yeast, flies, and worms (Haigis and Guarente, 2006; Kaeberlein
et al., 1999; Mouchiroud et al., 2013), but their effects and extent
in lifespan extension have been challenged (Burnett et al., 2011).
Still, recent evidence in mammals suggests a connection be-
tween sirtuins and a longevity-promoting function; for example,
a study indicates that brain-specific overexpression of SIRT1 is
sufficient to promote longevity in mice (Satoh et al., 2013).
Overall, it is clear that resveratrol treatment or SIRT1 overexpres-
sion prevents several age-associated diseases and pathogenic
conditions, including oxidative stress in the aging heart, neuro-
degeneration, or diabetes (Haigis and Guarente, 2006). Impor-
tantly, activation of autophagy by resveratrol is required for
lifespan extension in Caenorhabditis elegans (C. elegans) (Mor-
selli et al., 2010).
Rapamycin, an inhibitor of the TOR kinase, is a natural product
secretedbya soil bacteriumoriginally discoveredonEaster Island
(also known as Rapa Nui, hence the name rapamycin). Before its
introduction in the antiaging field, rapamycin was already well
known as an immunosuppressive drug for the treatment of allo-
graft rejection. Rapamycin is a strong inducer of autophagy, and
it extends lifespan in all organisms tested so far, including yeast,
flies, worms, andmice (Bjedov and Partridge, 2011; Kapahi et al.,
2004). Middle-agedmice on a diet supplemented with rapamycin
survived significantly longer (Harrison et al., 2009); however, re-
ports of the potent immunosuppressive properties of rapamycin
suggest that the drug is unsuitable for lifespan extension in
humans. Moreover, long-term administration of rapamycin has
been found to cause a variety of adverse health effects in patients,
including impaired wound healing, anemia, proteinuria, pneumo-
nitis, and hypercholesterolemia. Chronic inhibition of mammalian
TOR (mTOR) function by rapamycin promotes insulin resistance
and diabetes in laboratory mice (Lamming et al., 2012). It is inter-
esting that intermittent rapamycin feeding, which was recently
shown to also increase lifespan in mice, opens up new opportu-
nities to avoid immunosuppression and its potentially detrimental
effects on lifespan extension (Anisimov et al., 2011a). Because of
its antiproliferative properties, rapamycin or its analogs (rapalogs)
are used as anticancer drugs (Benjamin et al., 2011; Guba et al.,
2002).
Spermidine is a naturally occurring polyamine that triggers
autophagy and is associated with lifespan extension when sup-
plemented in the food supply of yeast, flies, and worms (Eisen-
berg et al., 2009). Endogenous spermidine concentrations
decrease as the organism age, including in humans with the
exception of centenarians (Pucciarelli et al., 2012). Acute injec-
tions of spermidine inmice activate autophagy inmultiple organs
(Morselli et al., 2011), while chronic spermidine feeding pro-
motes increase in healthspan (Eisenberg et al., 2009). The
impact of long-term effects of spermidine on autophagy has
not been investigated. Spermidine has been found to impede a
number of neurological pathologies and induce neuronal auto-
phagy. It inhibits neurodegeneration and alleviates pathogenesis
and motor dysfunction in a mouse model for TDP-43 aggrega-
tion-induced frontotemporal dementia and amyotrophic lateral
sclerosis (Wang et al., 2012). Moreover, age-associated memory
loss in flies is reversed by spermidine in an autophagy-depen-
dent fashion (Gupta et al., 2013). In yeast cells, spermidine
controls transcription of autophagy-relevant genes through
hypoacetylation of several promoter regions (Eisenberg et al.,
2009). Intriguingly, the promoter region of ATG7, an essential
autophagy gene, remains selectively acetylated, which allows
for its transcription in a state of general gene silencing (Eisenberg
et al., 2009). Lifespan extension in two short-livedmousemodels
has been reported after either oral administration of spermidine
or the upregulation of bacterial polyamine production in the gut
(Matsumoto et al., 2011; Soda et al., 2009). It is possible that fac-
tors other than polyamines are also secreted by gut bacteria to
influence longevity.
Metformin, a biguanide first isolated from the French lilac, is
the most prescribed drug for the treatment of type-2 diabetes.
Metformin decreases hepatic gluconeogenesis and increases
insulin sensitivity (Berstein, 2012). It is a potent, indirect activator
of adenosine monophosphate-acti vated protein kinase (AMPK)
(Scarpello andHowlett, 2008), an enzyme involved in cellular and
whole-organism energy balance, as well as in glucose and fat
metabolism. Interestingly, AMPK is also induced by CR. Upon
metformin exposure, AMPK is activated by an increase of the
AMP/ATP ratio, thereby inhibiting mTOR, a protein kinase
involved in the control of cellular proliferation and tumor growth
(Dazert and Hall, 2011). Although the direct target of metformin
is not known, it indirectly inhibits complex I of the electron
transport chain (El-Mir et al., 2000). Therefore, metformin
compromises ATP production in mitochondria, leading to an
increase of the AMP/ATP ratio without ROS accumulation. The
transcription factor SKN-1/Nrf2 is activated upon metformin
treatment, resulting in increased expression of antioxidant genes
and subsequent protection from oxidative damage (Berstein,
2012). Metformin increases the mean and maximum lifespan indifferent female mouse strains predisposed to high incidence
of mammary tumors (Anisimov et al., 2011b; Martin-Montalvo
et al., 2013). Recently, many laboratories, including ours, have
tested pharmacological interventions as CR mimetics that can
delay aging and the incidence of age-related diseases (Anisimov
et al., 2011b; Baur et al., 2006; Harrison et al., 2009; Martin-
Montalvo et al., 2013). Some metabolic effects of metformin
resemble those of CR, even though food intake was increased
(Anisimov et al., 2011b; Martin-Montalvo et al., 2013). At a
biochemical level, metformin supplementation is associated
with inhibition of chronic inflammation and reduction in markers
of oxidative stress, two well-known factors that compromise
health and lifespan (Martin-Montalvo et al., 2013). There are
now several reports demonstrating that the effects of metformin
on transcription mimic the gene expression profile of animals on
CR through the transcriptional regulatory pathways controlling




The first lifespan-extending genetic alteration described was
a mutation in the phosphatidylinositol 3-kinase (PI3K) of
C. elegans (Friedman and Johnson, 1988). PI3K is a downstream
component of the insulin receptor signaling pathway, and dele-
tion of the nematode’s insulin receptor (daf-2) also results in
longevity (Kenyon et al., 1993). The fact that a double-knockout
mutant showed no additional effect suggested an epistatic inter-
action between the twomutations (Dorman et al., 1995). Lifespan
in yeast, flies, and mice is extended in response to nutrient
deprivation or following the disruption and/or genetic downregu-
lation of insulin and IGF signaling (Holzenberger et al., 2003).
PI3Ks phosphorylate phosphatidylinositol-4,5-bisphosphate to
generate phosphatidylinositol-3,4,5-trisphosphate, which acts
as a second messenger for downstream activation of protein
kinase B (AKT/PKB). Deletion of AKT/PKB prolongs life in
S. cerevisiae,C. elegans, and Drosophila melanogaster (Fontana
et al., 2010). Metazoan TOR, the master regulator of growth and
inhibitor of autophagy, is upregulated by the PI3K/AKT/PKB
cascade. Of significance, TOR inactivation extends lifespan in
yeast (Kaeberlein et al., 2005), flies (Kapahi et al., 2004), worms
(Vellai et al., 2003), and mice (Harrison et al., 2009).
IGF1 is the major growth factor in mammals, and high levels of
IGF1 can cause rapid aging and cancer (Fontana et al., 2010).
Mutations that decrease IGF1 levels or activity cause reduced
growth and longer life in mice by up to 65% (Coschigano et al.,
2000; Holzenberger et al., 2003). A group of Ecuadorians with
an IGF1-signaling deficiency due to mutations in the growth
hormone receptor gene exhibits dwarfism and virtually no age-
associated diseases, such as cancer or diabetes (Fontana
et al., 2010). It is interesting that mutations that extend lifespan
also result in energy storage either in the form of glycogen, fat,
or both, in virtually all tested models. Indeed, IGF1 deficiency
causes greater fat accumulation in humans (Laron and Klinger,
1993). Most antiaging regimens elicit a drop in circulating IGF1,
as evidenced by the fact that a 5 day fasting period lowers
IGF1 plasma levels by more than 60% and causes a significant
increase in IGFBP-1, one of the principal IGF1-inhibiting proteinsCell 157, June 19, 2014 ª2014 Elsevier Inc. 1521
(Longo and Mattson, 2014). Protein restriction is required for the
reduction of IGF1 levels during CR in humans (Fontana et al.,
2010). In rodents, a protein-restricted diet given every other
week (without CR) is sufficient to lower circulating IGF1 and
increase IGFBP-1 levels, resulting in improved cognitive ability
of mice with Alzheimer’s disease-like symptoms (Longo and
Mattson, 2014). These findings are in line with recent studies
from calorie-restricted humans, which show reduced serum
levels of IGF1 only when protein intake is restricted (Fontana
et al., 2010). These observations, coupled with the fact that
reducing nutrient intake and disrupting TOR are antiaging inter-
ventions, suggest that nutrient signaling has evolved from a
primordial starvation response to a molecular mechanism of
health and lifespan extension.
Autophagy
Autophagy (from the Greek ‘‘self-eating’’) is a catabolic process
that degrades defective and expandable cellular components for
recycling. It ensures that sufficient energy levels are maintained
(for instance upon starvation) and, at the same time, eliminates
damaged cellular material (Klionsky, 2007; Levine and Kroemer,
2008). CR is a strong inducer of autophagy, whichmay be an effi-
cient strategy to maintain life under times of scarce resources.
This process would enhance the probability of survival until
nutrients become available and thereby allowmating and recom-
bination. In mice, overexpression of Atg5, a gene essential for
autophagy, is sufficient to activate autophagy and extend life-
span (Pyo et al., 2013). In nematodes, lifespan is extended either
by CR, rapamycin-mediated inhibition of TOR signaling (a key
negative regulator of autophagy), or knockdown of the cyto-
plasmic portion of the p53 ortholog encoded by cep-1, a tumor
suppressor and autophagy inhibitor (Jia and Levine, 2007;
Tavernarakis et al., 2008). The fact that knocking down genes
essential for autophagy abrogates lifespan extension in worms
(Jia and Levine, 2007; Tavernarakis et al., 2008) argues for a
causal link between autophagy and longevity.
Autophagy and the expression/activity of sirtuins have been
functionally linked in the antiaging effects of CR, which has
generated an intense scientific debate (Kaeberlein et al., 2004,
2005; Burnett et al., 2011). However, several lines of evidence
suggest a closer connection of autophagy and sirtuins than
previously assumed, and it involves the acetylproteome. In
fact, both the autophagy inducer spermidine and the sirtuin
activator resveratrol create a repressive chromatin state. Sper-
midine inhibits histone acetyltransferase activity, whereas
resveratrol activates the counteracting histone deacetylase (sir-
tuin) activity (Morselli et al., 2010). Moreover, both compounds
also seem to affect the acetylproteome outside the nucleus,
through deacetylation of the autophagy-related factor Atg5
(Morselli et al., 2011). Indeed, SIRT1 is required for the induction
of autophagy in mice (Lee et al., 2008) and in human cells sub-
jected to either resveratrol treatment or nutrient starvation, and
in C. elegans under CR (Morselli et al., 2010). Conversely, life-
span extensionmediated by SIRT1 overexpression or resveratrol
administration is eliminated when beclin 1, a protein required for
autophagy induction, is knocked down (Morselli et al., 2010).
Even though spermidine and resveratrol promote autophagy
through distinct mechanisms, some convergence occurs at the
level of regulators and/or effectors of autophagy (Morselli1522 Cell 157, June 19, 2014 ª2014 Elsevier Inc.et al., 2011). Thus, it appears that autophagy induction may be
the result of a combination of transcriptional and cytoplasmic
(transcription-independent) events that influence the cellular
acetylproteome. In fact, acetyl-CoA controls longevity and auto-
phagy in a number of model systems (Eisenberg et al., 2014;
Marin˜o et al., 2014) by integrating various nutrition pathways
and by being the only known donor in acetylation reactions.
This suggests that acetyl-CoA may be a sensor, integrator, and
transducer of both the adverse consequences of overeating
and the protective effects of CR.
As an organism ages, more fat accumulates and the capacity
to induce autophagy decreases (Singh et al., 2009). Recent
research indicates that these two phenomena are causally con-
nected, because the autophagic machinery is also required for
the buildup of lipid stores. Thus, autophagy may be constrained
by the presence of excess fat, while also participating in lipolysis
through the vacuolar breakdown of lipids, a process known as
lipoautophagy (Singh et al., 2009). An interesting possibility is
that autophagy and lipolysis may also be linked through sirtuins,
although this remains to be explored. Nevertheless, there
appears to be a connection between fasting (as an inducer of
autophagy), sirtuin activation, and fat metabolism. For instance,
SIRT1 expression in human adipose tissue is decreased in obese
women but restored upon fasting (Pedersen et al., 2008). The
mitochondrial sirtuin paralog SIRT3 stimulates fasting-induced
fatty acid oxidation in mice via deacetylation-mediated activa-
tion of long chain acyl-CoA dehydrogenase (LCAD) (Hirschey
et al., 2010). In addition, resveratrol promotes lipolysis, attenu-
ates lipogenesis, and prolongs the lifespan of mice on a high-
fat diet (Baur et al., 2006).
Hormesis
In the 1980s, several toxicologists coined the term hormesis to
describe the protective effects conferred by the exposure to
low (subtoxic) doses of stressors or even toxins (Calabrese
et al., 1987). Indeed, an adaptive stress response elicited by a
noxious agent, be it of a chemical, thermal, or radiological
nature, renders an organism (or a cell) resistant to a larger and
otherwise lethal dose of the same agent (Calabrese et al.,
1987). For example, yeast cells that have been exposed to a
low dose of reactive oxygen species (ROS) before being chal-
lenged with toxic levels of oxidative stress exhibit a marked anti-
stress response and delay in subsequent death (Thorpe et al.,
2004). During ischemic preconditioning in humans, transient
and weak ischemic episodes can protect the brain and the heart
against a more severe oxygen deprivation (Martins et al., 2011).
Similarly, the lifelong and periodic exposure to various stressors
may be important to inhibit or retard the aging process, which
can be considered amajor stressor (Pan et al., 2011). Consistent
with this concept, heat or mild doses of oxidative stress can lead
to lifespan extension in C. elegans (Cypser et al., 2006) and, in
yeast, subtoxic levels of hydrogen peroxide are even essential
for lifespan extension by CR (Mesquita et al., 2010). Concor-
dantly, CR results in the activation of various antistress trans-
cription factors, such as Rim15, Gis1, and Msn2/Msn4 in yeast
and FOXO in mammals, to enhance the expression of a panel
of various ROS-scavenging factors and heat shock proteins.
Moreover, resveratrol triggers the ER stress response (Wang
et al., 2011) and rapamycin elicits an oxidative stress response
in stem cells (Kofman et al., 2012). One can conclude that the
antiaging effects of periodic fasting and treatment with resvera-
trol, rapamycin, or spermidine are based, at least in part, on
hormesis.
Mitochondrial Function
More than six decades ago, oxidative stress was proposed to be
a causal trigger for aging (Harman, 1956). Harman speculated
that mitochondria are the source of excess ROS during aging
and hence represent the central organelles in aging progression.
Although the oxidative radical theory of aging is still controver-
sial, the concept of ROS being the driving force behind the detri-
mental effects of aging remains a hot topic, in part due to the
consensus that mitochondrial alterations play a key regulatory
role in aging. A number of nuclear-encoded mitochondrial pro-
teins, including those residing in Complex I and IV of the electron
transport chain, are required for lifespan extension during CR in
flies (Zid et al., 2009). The expression of these mitochondrial
genes is regulated at the translational level by the translation
repressor d4E-BP, a protein required for maximal lifespan exten-
sion uponCR. It appears that upregulation of active d4E-BP, nor-
mally inhibited by TOR in response to nutrients, is sufficient to
extend lifespan of flies on a rich diet (Zid et al., 2009). This mech-
anism might be a means to mediate a metabolic shift toward
increased mitochondrial capacity during nutrient shortage (Zid
et al., 2009). From a hormetic point of view, the generation of
constant but low doses of ROSbymitochondriamay enable cells
to adapt to ROS-inflicted damage and thus to survive higher
ROS levels.
Mitochondrial respiratory thresholds regulate yeast chrono-
logical lifespan and its CR-mediated extension, probably by
increasing stress resistance (Ocampo et al., 2012). An important
element of stress resistance is the optimal accumulation and
mobilization of nutrient stores. In fact, mitochondria isolated
from yeast on CR show elevated respiration, increased ROS
levels, and an enhanced antioxidant defense system (Sharma
et al., 2011), indicating that CR may elicit mitohormetic effects
with resultant life extension. In line with these results, transgenic
mice overexpressing human catalase targeted solely to the
mitochondria (not to the peroxisome or the nucleus) live longer
and have less cardiac pathology (Schriner et al., 2005). Paradox-
ically, it is the impairment of mitochondrial function and asso-
ciated lower ATP levels that prolongs lifespan in worms (Dillin
et al., 2002; Lee et al., 2003). Mutations in the mitochondrial
leucyl-tRNA synthetase gene (lrs-2) disturb mitochondrial func-
tion, thus leading to lower ATP content, impaired oxygen con-
sumption, and longer lifespan (Lee et al., 2003). Taken together,
these results indicate a key modulatory role of mitochondria
during aging.
Conclusions
The purpose of aging research is the identification of inter-
ventions that may avoid or ameliorate the ravages of time. In
other words, the quest is for healthy aging, where improved
longevity is coupled to a corresponding healthspan extension.
Unfortunately, numerous claims about substances or behaviors
predicted to hold such benefits have been proven erroneous.
In recent years, however, fasting and exercise regimens, and a
number of small molecules have been shown to prolong lifeand/or sustain health late in life in model organisms as different
as yeast and monkeys. All these interventions are compatible
with the concept of programmed aging and, thus, amenable to
interventions aimed at modulating molecular components and
pathways responsible for the aging process. Autophagy upregu-
lation, improved stress resistance, and mitochondrial efficiency
are among the cellular functions needed to hold off features
associated with accelerated aging, such as free radical gene-
ration, excess caloric intake, chronic hyperglycemia, and fat
accumulation. More research is needed to gain further insights
into the long-term effects of these interventions alone and in
combination, and clarify their applicability to humans. The
current epidemics of obesity, diabetes, and related disorders
constitute major impediments for healthy aging. It is only by
extending the healthy human lifespan that we will truly meet
the premise of the Roman poet Cicero: ‘‘No one is so old as to
think that he may not live a year.’’
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